Physician profile
Daniel Blascak
NPI 1447643564
$4,178.90
in general payments reported to CMS, 2019-2025
12 companies · $818 in 2025
The $818 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,620 · 2023: $932 · 2024: $809 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,219 · Education: $340.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,219.03 |
| Education | $339.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pinnacle, INC | $1,447.39 | 2022-2025 | |
| Depuy Synthes Sales INC. | $703.46 | 2022-2025 | Na, Va-Lcp, Inhance |
| Medical Device Business Services, INC. | $619.98 | 2022-2025 | Actis |
| Stryker Corporation | $548.79 | 2023-2025 | T2 Alpha, Gamma, Axsos |
| Smith+Nephew, INC. | $214.66 | 2022-2023 | Healicoil, Firstpass, N/A |
| Si-Bone, INC. | $134.00 | 2023 | |
| Integra Lifesciences Corporation | $132.48 | 2023 | Tenoglide |
| Vertex Pharmaceuticals Incorporated | $121.84 | 2025 | |
| Heron Therapeutics, INC. | $111.50 | 2024 | Zynrelef |
| Endo Pharmaceuticals INC. | $108.40 | 2023 | Xiaflex |
| My01 INC. | $22.61 | 2023-2025 | My01 Continuous Compartmental Pressure Monitor |
| Acumed LLC | $13.79 | 2023 | Acumed |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Blascak listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.